Treatment of Constipation in Functional Dyspepsia
NCT02956187 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2018-01-19
Summary
Background. Functional dyspepsia is characterized by symptoms that apparently originate in the stomach without detectable cause by conventional diagnosis test. The pathophysiology of functional dyspepsia is not known, but a number of data indicate that dyspeptic patients have increased sensitivity of the digestive system, so that physiological stimuli may induce their symptoms. Some patients with functional dyspepsia have also functional constipation and the investigators hypothesize that in them constipation triggers or facilitates dyspeptic symptoms, and consequently, correction of constipation relieves dyspeptic symptoms.
Objective. To demonstrate the superiority of biofeedback versus a fiber supplement for the treatment of dyspeptic symptoms in patients with constipation due to functional outlet obstruction.
Design. Randomized, controlled parallel trial performed in a referral center. Participants. Consecutive patients complaining of symptoms of functional dyspepsia and functional outlet obstruction.
Interventions: Patients will be assigned to experimental (biofeedback for functional outlet obstruction) and active comparator (fiber supplementation) arms. Biofeedback for functional outlet obstruction: sessions of biofeedback guided by anorectal manometry (performed during the first 3 weeks of the intervention period) combined with instructions for daily exercising for 4 weeks. Fiber supplementation: 2.5 g plantago ovata per day for 4 weeks. Main outcome and measures. Clinical symptoms of functional dyspepsia measured by daily questionnaires for 7 consecutive days before and during the last week of intervention.
Relevance. Functional Dyspepsia, defined by purely clinical criteria, brings together a diverse group of conditions with different pathophysiology. As a result, the treatment is empirical and globally inefficient. This study will identify a subset of patients with a common pathophysiological mechanism of dyspeptic symptoms (functional outlet obstruction) which respond to specific treatment (biofeedback).
Conditions
- Dyspepsia
- Constipation
Interventions
- BEHAVIORAL
-
Biofeedback
Functional outlet obstruction will be treated by biofeedback: sessions of biofeedback guided by anorectal manometry combined with instructions for daily exercizing for 4 weeks.
- DIETARY_SUPPLEMENT
-
Fiber supplement
3.5 g plantago ovata per day will be administered for 4 weeks.
Sponsors & Collaborators
-
Hospital Universitari Vall d'Hebron Research Institute
lead OTHER
Principal Investigators
-
Fernando Azpiroz, MD · Principal Investigator
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-12
- Primary Completion
- 2017-12-10
- Completion
- 2018-01-08
Countries
- Spain
Study Locations
More Related Trials
-
Nutrition to Relieve IBS Constipation
NCT04798417 ·Status: COMPLETED ·Phase: NA
-
Marine Protein Hydrolysate as Dietary Supplement in Irritable Bowel Syndrome
NCT03801057 ·Status: COMPLETED ·Phase: NA
-
Study of Endogenous Inhibitory Modulation During Gastric and Somatic Stimulation
NCT00693407 ·Status: COMPLETED ·Phase: NA
-
Nutrition to Relieve IBS Symptoms by Targeting the Microbiota
NCT04790422 ·Status: COMPLETED ·Phase: NA
-
A Heart Rate Variability (HRV) Biofeedback Training in Functional Gastrointestinal Disorders (FGID)
NCT06687057 ·Status: RECRUITING ·Phase: NA
-
Efficacy of a Probiotic Blend to Reduce Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome
NCT05819281 ·Status: UNKNOWN ·Phase: PHASE2
-
Factors Affecting Dissatisfaction to Treatments in Patients With Chronic Constipation and IBS With Constipation
NCT02813616 ·Status: COMPLETED
-
A Novel Formulation of Bifidobacterium Longum BB536 and Lactobacillus Rhamnosus HN001 With Vitamin B6 on IBS Patients
NCT03815617 ·Status: COMPLETED ·Phase: PHASE3
-
"Functional Bowel Disorder. Investigation in General Practice"
NCT01153295 ·Status: COMPLETED ·Phase: NA
-
Does Small Intestinal Bacterial Overgrowth Contribute to Functional Dyspepsia
NCT00956397 ·Status: COMPLETED ·Phase: NA
-
The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients
NCT02254629 ·Status: COMPLETED ·Phase: PHASE1
-
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
NCT03687814 ·Status: RECRUITING ·Phase: NA
-
Fecal Microbiota Transplantation to Relieve Symptoms of Irritable Bowel Syndrome Without Constipation
NCT05803980 ·Status: RECRUITING ·Phase: NA
-
Fecal Microbiota Transplantation to Relieve Symptoms of Irritable Bowel Syndrome With Constipation
NCT05803993 ·Status: RECRUITING ·Phase: NA
-
Functional Digestive Disorders Observatory
NCT04918329 ·Status: RECRUITING
-
Effect of Fecal Microbiota Transplantation in Irritable Bowel Syndrome
NCT02788071 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Impact of Diet on Functional Gastrointestinal Symptoms
NCT03102411 ·Status: COMPLETED
-
Intracolonic FODMAP Infusion in Healthy Volunteers
NCT06488534 ·Status: COMPLETED ·Phase: NA
-
Manipulation of Visceral Sensitivity and Immune System in IBS
NCT00418340 ·Status: UNKNOWN ·Phase: PHASE4
-
Patient Attributes for Optimal Treatment Outcome in Irritable Bowel Syndrome.
NCT01297556 ·Status: UNKNOWN ·Phase: NA
-
Reliability of a Food Frequency Questionnaire in the Assessment of Dietary Intake Including FODMAPs in Different Populations, and Relationship With IBS Symptoms and the Degree of Self-assessed Physical Activity
NCT05293769 ·Status: RECRUITING
-
Probiotics and Gut Health
NCT01874301 ·Status: COMPLETED ·Phase: NA
-
Cognitive Behavioral Therapy With Our Without Exposure Therapy for Irritable Bowel Syndrome
NCT01529567 ·Status: COMPLETED ·Phase: NA
-
The Role of FODMAPs in Upper GI Effects, Colonic Motor Activity and Gut-brain Signaling at the Behavioral Level
NCT02980406 ·Status: COMPLETED ·Phase: NA
-
The Effect of a Low FODMAP Diet in Functional Dyspepsia Patients With Meal Related Symptoms
NCT06388330 ·Status: COMPLETED ·Phase: NA